Imatinib treatment and Aβ42 in humans

Alzheimer's and Dementia

Volumn 10, Issue 5, 2014, Pages S374-S380

  Olsson, Bob ^a   Legros, Laurence ^b   Guilhot, François ^c   Strömberg, Kia ^d   Smith, James ^e   Livesey, Frederick J ^e   Wilson, David H ^f   Zetterberg, Henrik ^a,g   Blennow, Kaj ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d ASTRAZENECA R AND D   (Sweden)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f QUANTERIX CORPORATION   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; A 42; CML; Imatinib; Plasma

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE INHIBITOR; GAMMA SECRETASE INHIBITOR; IMATINIB; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); APP PROTEIN, HUMAN; BENZAMIDE DERIVATIVE; PEPTIDE FRAGMENT; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; SECRETASE;

ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN CORTEX; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DOWN SYNDROME; EMBRYO; EMBRYONIC STEM CELL; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOUSE; MULTICENTER STUDY (TOPIC); NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIMARY CELL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; RANDOMIZED CONTROLLED TRIAL (TOPIC); AGED; ALZHEIMER DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL CULTURE; DRUG EFFECTS; FEMALE; GENETICS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BENZAMIDES; CELLS, CULTURED; CEREBRAL CORTEX; DOWN SYNDROME; EMBRYONIC STEM CELLS; FEMALE; HEK293 CELLS; HUMANS; IMATINIB MESYLATE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MICE; NEURONS; PEPTIDE FRAGMENTS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 84908229409     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.08.283     Document Type: Article

References (30)

1. A. Alzheimer Über eine eigenartige Erkrankung der Hirnrinde Allg Z Psychiat 64 1907 146 148
2. K. Blennow, M.J. de Leon, and H. Zetterberg Alzheimer's disease Lancet 368 2006 387 403
3. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski, and L.I. Binder Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proc Natl Acad Sci U S A 83 1986 4913 4917
4. J. Kang, H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, and K.H. Grzeschik The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325 1987 733 736
5. N.K. Robakis, N. Ramakrishna, G. Wolfe, and H.M. Wisniewski Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides Proc Natl Acad Sci U S A 84 1987 4190 4194
6. R.E. Tanzi, J.F. Gusella, P.C. Watkins, G.A. Bruns, P. St George-Hyslop, and M.L. Van Keuren Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus Science 235 1987 880 884
7. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, and P. Denis Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741
8. P. St George-Hyslop, and P.E. Fraser Assembly of the presenilin gamma-/epsilon-secretase complex J Neurochem 120 suppl 1) 2012 84 88
9. W.J. Netzer, F. Dou, D. Cai, D. Veach, S. Jean, and Y. Li Gleevec inhibits beta-amyloid production but not Notch cleavage Proc Natl Acad Sci U S A 100 2003 12444 12449
10. E. Buchdunger, J. Zimmermann, H. Mett, T. Meyer, M. Muller, and B.J. Druker Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative Cancer Res 56 1996 100 104
11. M. Baccarani, G. Saglio, J. Goldman, A. Hochhaus, B. Simonsson, and F. Appelbaum Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet Blood 108 2006 1809 1820
12. J.D. Rowley Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature 243 1973 290 293
13. P. Nowell, and D. Hungerford A minute chromosome in human chronic granulocytic leukemia [abstract] Science 132 1960 1497
14. J. Groffen, J.R. Stephenson, N. Heisterkamp, A. de Klein, C.R. Bartram, and G. Grosveld Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 Cell 36 1984 93 99
15. E. Shtivelman, B. Lifshitz, R.P. Gale, and E. Canaani Fused transcript of abl and bcr genes in chronic myelogenous leukaemia Nature 315 1985 550 554
16. G. He, W. Luo, P. Li, C. Remmers, W.J. Netzer, and J. Hendrick Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease Nature 467 2010 95 98
17. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
18. D.M. Rissin, C.W. Kan, T.G. Campbell, S.C. Howes, D.R. Fournier, and L. Song Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations Nat Biotechnol 28 2010 595 599
19. H. Zetterberg, E. Mortberg, L. Song, L. Chang, G.K. Provuncher, and P.P. Patel Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid beta levels in humans PLoS One 6 2011 e28263
20. Y. Shi, P. Kirwan, J. Smith, G. MacLean, S.H. Orkin, and F.J. Livesey A human stem cell model of early Alzheimer's disease pathology in Down syndrome Sci Transl Med 4 2012 124ra129
21. Y. Shi, P. Kirwan, J. Smith, H.P. Robinson, and F.J. Livesey Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses Nat Neurosci 15 2012 477 486 S1
22. M. Citron, T. Oltersdorf, C. Haass, L. McConlogue, A.Y. Hung, and P. Seubert Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production Nature 360 1992 672 674
23. M. Mullan, F. Crawford, K. Axelman, H. Houlden, L. Lilius, and B. Winblad A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid Nat Genet 1 1992 345 347
24. W.B. Zigman, and I.T. Lott Alzheimer's disease in Down syndrome: neurobiology and risk Ment Retard Dev Disabil Res Rev 13 2007 237 246
25. W.E. Van Nostrand, A.H. Schmaier, J.S. Farrow, and D.D. Cunningham Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein Science 248 1990 745 748
26. U. Monning, G. Konig, R. Prior, H. Mechler, U. Schreiter-Gasser, and C.L. Masters Synthesis and secretion of Alzheimer amyloid beta A4 precursor protein by stimulated human peripheral blood leucocytes FEBS Lett 277 1990 261 266
27. B.J. Druker, M. Talpaz, D.J. Resta, B. Peng, E. Buchdunger, and J.M. Ford Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 2001 1031 1037
28. M.K. Weintraub, C.M. Bisson, J.N. Nouri, B.T. Vinson, M.J. Eimerbrink, and D. Kranjac Imatinib methanesulfonate reduces hippocampal amyloid-beta and restores cognitive function following repeated endotoxin exposure Brain Behav Immun 33 2013 24 28
29. A.L. Petzer, E. Gunsilius, M. Hayes, G. Stockhammer, H.C. Duba, and F. Schneller Low concentrations of STI571 in the cerebrospinal fluid: a case report Br J Haematol 117 2002 623 625
30. C.R. Burton, J.E. Meredith, D.M. Barten, M.E. Goldstein, C.M. Krause, and C.J. Kieras The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expression J Biol Chem 283 2008 22992 23003